These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36795807)

  • 1. Possible psychedelic therapeutic mechanism.
    Hess EM; Gould TD
    Science; 2023 Feb; 379(6633):642-643. PubMed ID: 36795807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors.
    Vargas MV; Dunlap LE; Dong C; Carter SJ; Tombari RJ; Jami SA; Cameron LP; Patel SD; Hennessey JJ; Saeger HN; McCorvy JD; Gray JA; Tian L; Olson DE
    Science; 2023 Feb; 379(6633):700-706. PubMed ID: 36795823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-HT
    Schmitz GP; Jain MK; Slocum ST; Roth BL
    ACS Chem Neurosci; 2022 Aug; 13(16):2386-2398. PubMed ID: 35894503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychedelics and schizophrenia.
    González-Maeso J; Sealfon SC
    Trends Neurosci; 2009 Apr; 32(4):225-32. PubMed ID: 19269047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens.
    Rickli A; Moning OD; Hoener MC; Liechti ME
    Eur Neuropsychopharmacol; 2016 Aug; 26(8):1327-37. PubMed ID: 27216487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychedelics and Personality.
    Aixalà M; Dos Santos RG; Hallak JEC; Bouso JC
    ACS Chem Neurosci; 2018 Oct; 9(10):2304-2306. PubMed ID: 29863323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychedelic Psychiatry's Brave New World.
    Nutt D; Erritzoe D; Carhart-Harris R
    Cell; 2020 Apr; 181(1):24-28. PubMed ID: 32243793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hallucinogens and Serotonin 5-HT
    López-Giménez JF; González-Maeso J
    Curr Top Behav Neurosci; 2018; 36():45-73. PubMed ID: 28677096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged epigenomic and synaptic plasticity alterations following single exposure to a psychedelic in mice.
    de la Fuente Revenga M; Zhu B; Guevara CA; Naler LB; Saunders JM; Zhou Z; Toneatti R; Sierra S; Wolstenholme JT; Beardsley PM; Huntley GW; Lu C; González-Maeso J
    Cell Rep; 2021 Oct; 37(3):109836. PubMed ID: 34686347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Selective" serotonin 5-HT
    Casey AB; Cui M; Booth RG; Canal CE
    Biochem Pharmacol; 2022 Jun; 200():115028. PubMed ID: 35381208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative phosphoproteomics unravels biased phosphorylation of serotonin 2A receptor at Ser280 by hallucinogenic versus nonhallucinogenic agonists.
    Karaki S; Becamel C; Murat S; Mannoury la Cour C; Millan MJ; Prézeau L; Bockaert J; Marin P; Vandermoere F
    Mol Cell Proteomics; 2014 May; 13(5):1273-85. PubMed ID: 24637012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible Interactions Between 5-HT2A Receptors and the Endocannabinoid System in Humans: Preliminary Evidence of Interactive Effects of Ayahuasca and Endocannabinoids in a Healthy Human Subject.
    Dos Santos RG; Crippa JA; Osório FL; Rocha JM; Rossi GN; Marchioni C; Queiroz MEC; Silveira GO; Yonamine M; Hallak JEC
    J Clin Psychopharmacol; 2018 Dec; 38(6):644-646. PubMed ID: 30339603
    [No Abstract]   [Full Text] [Related]  

  • 13. Natural psychedelics in the treatment of depression; a review focusing on neurotransmitters.
    Jahanabadi S; Amiri S; Karkeh-Abadi M; Razmi A
    Fitoterapia; 2023 Sep; 169():105620. PubMed ID: 37490982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Animal models of serotonergic psychedelics.
    Hanks JB; González-Maeso J
    ACS Chem Neurosci; 2013 Jan; 4(1):33-42. PubMed ID: 23336043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dark Classics in Chemical Neuroscience: N, N-Dimethyltryptamine (DMT).
    Cameron LP; Olson DE
    ACS Chem Neurosci; 2018 Oct; 9(10):2344-2357. PubMed ID: 30036036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The serotonin 5-HT
    Canal CE; Murnane KS
    J Psychopharmacol; 2017 Jan; 31(1):127-143. PubMed ID: 27903793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychedelics as an emerging novel intervention in the treatment of substance use disorder: a review.
    DiVito AJ; Leger RF
    Mol Biol Rep; 2020 Dec; 47(12):9791-9799. PubMed ID: 33231817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enlightening the "Spirit Molecule": Photomodulation of the 5-HT
    Gerwe H; He F; Pottie E; Stove C; Decker M
    Angew Chem Int Ed Engl; 2022 Jun; 61(26):e202203034. PubMed ID: 35349196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a hallucinogenic serotonin 5-HT
    Zhang G; Cinalli D; Stackman RW
    Hippocampus; 2017 May; 27(5):558-569. PubMed ID: 28176400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonist properties of N,N-dimethyltryptamine at serotonin 5-HT2A and 5-HT2C receptors.
    Smith RL; Canton H; Barrett RJ; Sanders-Bush E
    Pharmacol Biochem Behav; 1998 Nov; 61(3):323-30. PubMed ID: 9768567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.